Colibri Heart Valve LLC has developed a pre-packaged and sterilized aortic heart valve that it thinks will further propel the transcatheter aortic heart valve implantation (TAVI) market. Its ready-for-use device has a profile that is roughly 20% to 40% less than the current market leaders, so patients with smaller femoral arteries who are currently excluded can benefit from TAVI.
